Genzyme Reacquires Arthritis Pain Treatment from Wyeth
By Business Review Editor
Pharma Deals Review: Vol 2005 Issue 55 (Table of Contents)
Published: 5 Jan-2005
DOI: 10.3833/pdr.v2005.i55.741 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Genzyma reacquired the sales and marketing rights to Synvisc® (hylan G-F 20), an arthritis pain treatment, from Wyeth...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS